BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18196747)

  • 21. Evaluation of neutrophilia as a prognostic factor in dogs with multicentric lymphoma treated with a cyclophosphamide, doxorubicin, vincristine, and prednisone-based chemotherapy protocol.
    Veluvolu S; Pellin M; Vos N
    J Am Vet Med Assoc; 2021 Sep; 259(5):494-502. PubMed ID: 34388019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma.
    Marquardt TM; Lindley SES; Smith AN; Cannon CM; Rodriguez CO; Thamm DH; Childress MO; Northrup NC
    J Am Vet Med Assoc; 2019 Jan; 254(2):236-242. PubMed ID: 30605381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma.
    Rassnick KM; McEntee MC; Erb HN; Burke BP; Balkman CE; Flory AB; Kiselow MA; Autio K; Gieger TL
    J Vet Intern Med; 2007; 21(6):1364-73. PubMed ID: 18196748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.
    Alvarez FJ; Kisseberth WC; Gallant SL; Couto CG
    J Vet Intern Med; 2006; 20(5):1178-83. PubMed ID: 17063713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
    Myers NC; Moore AS; Rand WM; Gliatto J; Cotter SM
    J Vet Intern Med; 1997; 11(6):333-9. PubMed ID: 9470157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study.
    Baskin CR; Couto CG; Wittum TE
    J Am Anim Hosp Assoc; 2000; 36(5):404-9. PubMed ID: 10997515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
    Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
    J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
    Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
    J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cytoreductive efficacy of vincristine, cyclophosphamide, and Doxorubicin in dogs with lymphoma by measuring the number of neoplastic lymphoid cells with real-time polymerase chain reaction.
    Sato M; Yamazaki J; Goto-Koshino Y; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    J Vet Intern Med; 2011; 25(2):285-91. PubMed ID: 21314729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
    Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
    J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
    Curran K; Thamm DH
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():147-55. PubMed ID: 26279153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma.
    Moore AS; Cotter SM; Frimberger AE; Wood CA; Rand WM; L'Heureux DA
    J Vet Intern Med; 1996; 10(6):372-5. PubMed ID: 8947869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance treatment in relapsed canine lymphoma after a short L-CHOP protocol.
    Troedson K; Ignatenko N; Fejos C; Zablotski Y; Hirschberger J
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2021 Jun; 49(3):185-194. PubMed ID: 34157760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response-based modification of CHOP chemotherapy for canine B-cell lymphoma.
    Benjamin SE; Sorenmo KU; Krick EL; Salah P; Walsh KA; Weinstein NM; Keuler NS; Avery AC; Atherton MJ; Lenz JA
    Vet Comp Oncol; 2021 Sep; 19(3):541-550. PubMed ID: 33729654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.